Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (124)

1

Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy

enthalten in: Ophthalmology | 2015

von Letko, E. | Yeh, S. | Foster, C. | +4

2

Re : Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96)

enthalten in: Ophthalmology | 2014

von Onal, S. | Tugal-Tutkun, I.

CommentOn: Ophthalmology. 2014 Mar;121(3):785-96.e3. - PMID 24359625

3

Author reply : To PMID 24359625

enthalten in: Ophthalmology | 2014

von Read, R. | Levy-Clarke, G. | Jabs, D. | +3

CommentOn: Ophthalmology. 2014 Mar;121(3):785-96.e3. - PMID 24359625

4

Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders

enthalten in: Ophthalmology | 2014

von Levy-Clarke, G. | Jabs, D. | Read, R. | +3

CommentIn: Ophthalmology. 2014 Oct;121(10):e58-9. - PMID 25015217

5

Secukinumab in the treatment of noninfectious uveitis : results of three randomized, controlled clinical trials

enthalten in: Ophthalmology | 2013

von Dick, A. | Tugal-Tutkun, I. | Foster, S. | +4

CommentIn: Ophthalmology. 2013 Dec;120(12):e86. - PMID 24246836

6

Ranibizumab for Age-related Macular Degeneration

enthalten in: Ophthalmology | 2011

von Seider, M. | Stewart, J.

CommentOn: Ophthalmology. 2010 Nov;117(11):2134-40. - PMID 20591490

7

Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion : 12-month outcomes of a phase III study

enthalten in: Ophthalmology | 2011

von Brown, D. | Campochiaro, P. | Bhisitkul, R. | +6

8

Retinopathy of prematurity in the time of bevacizumab : incorporating the BEAT-ROP results into clinical practice

enthalten in: Ophthalmology | 2011

von Moshfeghi, D. | Berrocal, A.

CommentIn: Ophthalmology. 2012 Feb;119(2):431-2; author reply 432. - PMID 22305321

9

Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration : the EXCITE study

enthalten in: Ophthalmology | 2011

von Schmidt-Erfurth, U. | Eldem, B. | Guymer, R. | +8

10

Ranibizumab for retinal neovascularization

enthalten in: Ophthalmology | 2011

von Jorge, R. | Oliveira, R. | Messias, A. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]